Cleared Traditional

K813092 - ACCUPRO I.V. ADMINISTRATION SET

K813092 is the FDA 510(k) clearance for ACCUPRO I.V. ADMINISTRATION SET by American Mcgaw. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 59-day FDA review.

K813092 · American Mcgaw · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 1981
Decision
59d
Days
Class 2
Risk

K813092 is an FDA 510(k) clearance for the ACCUPRO I.V. ADMINISTRATION SET. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by American Mcgaw (Mchenry, US). The FDA issued a Cleared decision on December 31, 1981 after a review of 59 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Mcgaw devices

Submission Details

510(k) Number K813092 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 02, 1981
Decision Date December 31, 1981
Days to Decision 59 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
70d faster than avg
Panel avg: 129d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 466
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K813092.
CLIRANS PRIMING SET
K820788 · Terumo Medical Corp. · Apr 1982
THE INT-STOPPER
K820453 · Burron Medical Products, Inc. · Mar 1982
INTRAVASCULAR ADMINISTRATION SET
K820278 · Y · Feb 1982
IN-STOPPER (INJECTION CAP
K813259 · Burron Medical Products, Inc. · Dec 1981
AUTO-SYRINGE SUB-CUTEANEOUS SET
K813194 · Baxter Healthcare Corp · Dec 1981
VENOFIX SCALP VEIN SET
K813083 · Burron Medical Products, Inc. · Nov 1981